Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
about
Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its ComorbiditiesTGF-β/Smad signaling in renal fibrosisGenetic and epigenetic factors influencing chronic kidney diseaseThe AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblastsRole of the TGF-β/BMP-7/Smad pathways in renal diseasesAM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial CellsTurmeric: Reemerging of a neglected Asian traditional remedy.MXRA5 is a TGF-β1-regulated human protein with anti-inflammatory and anti-fibrotic propertiesRedox control of p53 in the transcriptional regulation of TGF-β1 target genes through SMAD cooperativity.New targets for renal interstitial fibrosis: relaxin family peptide receptor 1-angiotensin type 2 receptor heterodimers.Antifibrotic effects of KS370G, a caffeamide derivative, in renal ischemia-reperfusion injured mice and renal tubular epithelial cells.Rotenone remarkably attenuates oxidative stress, inflammation, and fibrosis in chronic obstructive uropathyPharmacological and genetic depletion of fibrinogen protects from kidney fibrosis.CCAAT-enhancer binding protein delta (C/EBPδ) attenuates tubular injury and tubulointerstitial fibrogenesis during chronic obstructive nephropathy.Molecular and clinical aspects of drug-induced gingival overgrowth.Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signalingNorcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition.Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System via HuR.Activation of autophagy and nucleotide-binding domain leucine-rich repeat-containing-like receptor family, pyrin domain-containing 3 inflammasome during Leishmania infantum-associated glomerulonephritisTransforming growth factor-β receptor 2 gene polymorphisms are associated with end-stage renal disease.Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells.Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.P311 promotes renal fibrosis via TGFβ1/Smad signaling.NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicityTreatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin.MnTBAP Therapy Attenuates Renal Fibrosis in Mice with 5/6 Nephrectomy.Yi Qi Qing Re Gao-containing serum inhibits lipopolysaccharide-induced rat mesangial cell proliferation by suppressing the Wnt pathway and TGF-β1 expressionThe emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.Role of the prostaglandin E2 receptor agonists in TGF-β1-induced mesangial cell damageTransforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3Vesicoureteral reflux and the extracellular matrix connection.Anti-fibrosis therapy and diabetic nephropathy.Aptamers and their potential to selectively target aspects of EGF, Wnt/β-catenin and TGFβ-smad family signaling.The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.Hypoacusia and chronic renal dysfunction: new etiopathogenetic prospective.The role of endoglin in kidney fibrosis.Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase.The role of hypoxia and Morg1 in renal injury.Alterations in the long non‑coding RNA transcriptome in mesangial cells treated with aldosterone in vitro.Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro.
P2860
Q26798487-C15DA01A-BB30-468B-AEAB-DC29C9766FDAQ26851198-ED0AEAE3-E9F8-4717-B0AC-35F079E0E95BQ27024548-39525877-892A-40C1-8AF7-A4CCB7760CB2Q27312584-906D87B0-B5CF-4818-A020-432BD57F19B8Q28278757-9BE608E4-F131-4A46-8580-336A6DDC7843Q28554943-1CA3EE87-C3B0-4C42-A866-18A3ADD22D40Q30486649-D1917104-5BE1-4FD8-B23D-1D1389CD1F46Q33112694-580931F6-9656-4E53-9958-88771FB08C1AQ33724429-6D7564ED-2335-49EF-850D-F77BA512C69EQ33827256-D396DC76-C784-444D-8273-83C076169EF6Q33941969-45D9A153-8A64-4F31-B68D-F0A6E69F7142Q34033183-206DF3E0-EDCE-4086-A709-F6A72CC08BE5Q34062853-78A66BEE-3BF0-4110-8282-E70B60CFDF9EQ34386023-21CD8354-E85C-4E17-A35F-C4B7B0FF95D9Q34462674-F9341F2B-197D-4518-A0F5-64D9F75876BDQ34559028-7AF0A005-885F-4DF3-8546-DADD180ACE53Q34794074-2599DDCE-23D8-4C44-97CC-2D2B12168063Q35920540-252A569C-3B40-46D8-A9A3-538D4A40E764Q35931804-479BE95A-49EC-455E-BF12-B6D4AA7602BDQ36061727-F54F74C7-087A-4A34-B09E-BC8AF63A3AD0Q36105288-94CA5676-A921-4B6F-A94E-950B46B2B0C8Q36126662-A600757D-6569-490F-9012-509DE1109022Q36330422-8A74764B-02E1-436B-86FE-3EF4F6C55390Q36363349-B24F6BAC-9165-4C29-A9D3-2D9D976A78DEQ36545653-7194890D-0EC3-45E3-89E9-3C28ABEFC05AQ36637619-E1D21594-3B44-45BF-8561-426FCCCA4154Q36740922-A1D83287-B5C7-41AB-86C4-8A1C5A9FF0A2Q37147122-BE6B254E-0F00-44EA-8329-E17AACEAE10AQ37294265-5FAFC168-0B4C-4E38-9B05-65585D1CBFB2Q37596473-88046C6B-F4EA-43B6-83CB-FB6F92D18B82Q37733382-E0536B24-C04B-4B01-BEB2-D22DDFD60104Q38014361-953FB99E-A317-4D4F-8B0B-4363932C5E27Q38093337-220197BF-AA73-4007-8E65-7C528CB207B4Q38104321-181E3AC1-7A8A-4426-8E48-40AC86149DD4Q38254461-0AE3797F-61BD-4E66-BB7E-540E7C7F55E1Q38273688-A5D349AF-573E-4A55-AD1E-06384F31E750Q38283016-E0ACB9ED-BFB3-4D39-8686-0C0116D60616Q38329848-D0A2F018-B3D8-45A7-A097-0A7A06AD59F0Q38429331-0CEF11A6-D133-4328-8625-46A40C556256Q38771700-C3575854-F72B-4F01-9734-55B0174BD561
P2860
Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Role of TGF-β in chronic kidne ...... omerular and vascular effects.
@en
Role of TGF-β in chronic kidne ...... omerular and vascular effects.
@nl
type
label
Role of TGF-β in chronic kidne ...... omerular and vascular effects.
@en
Role of TGF-β in chronic kidne ...... omerular and vascular effects.
@nl
prefLabel
Role of TGF-β in chronic kidne ...... omerular and vascular effects.
@en
Role of TGF-β in chronic kidne ...... omerular and vascular effects.
@nl
P2860
P1476
Role of TGF-β in chronic kidne ...... omerular and vascular effects.
@en
P2093
Francisco J López-Hernández
Jose M López-Novoa
P2860
P2888
P304
P356
10.1007/S00441-011-1275-6
P577
2011-11-22T00:00:00Z